Publication | Open Access

Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients

Distinct AdvantageAutoimmune DiseaseMedicineHematologyImmunologyBlood CellAutoimmunityVascular BiologyHeme HomeostasisPharmacologyComplement InhibitorsHeme Trafficking